Senegal becomes the first Francophone African country to achieve WHO maturity level 3 for pharmaceutical regulation. This recognition honors the efforts of the Senegalese Pharmaceutical Regulatory Agency (ARP) to ensure access to safe and effective medicines. The independent 2024 assessment highlights Senegal’s dedication to meeting the highest international standards.
